Acasti Pharma Inc

NASDAQ: ACST
$2.93
+$0.03 (+1.0%)
Closing price April 25, 2024
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and marketing of prescription drugs for the treatment of cardiovascular disease. The company is headquartered in Laval, Canada.
Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that blocked its patents on the medication Vascepa, the company’s chief executive says....